Integra LifeSciences Holdings Corporation with ticker code (IART) have now 10 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The target price High/Low ranges between 66 and 39 suggesting an average Analsyt target price of $54.20. Given that the stocks previous close was at $50.72 and the analysts are correct then we can expect a percentage increase in value of 6.9%. The 50 day moving average now sits at $54.15 and the 200 moving average now moves to $52.78. The company has a market capitalization of 3.32B. The stock price for Iron Mountain Incorporated is 40.48 USD
The potential market cap would be $3,542,972,409 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 19.28, revenue per share of 18.92 and a 4.56% return on assets.
Integra LifeSciences Holdings Corporation is a medical technology company. The Company operates through two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS segment consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield and Bactiseal. Its product offering includes CereLink in the Unites States and Europe. The Company’s TT segment focuses on three areas, which include complex wound surgery, surgical reconstruction and peripheral nerve repair. TT’s regenerative platform includes multiple brands, such as Integra Dermal Matrices, AmnioExcel, SurgiMend, MicroMatrix and NeuraGen. The Company’s manufacturing and research facilities are located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland.
